Published on April 3, 2026
In a recent discussion on the history of immunisation in India, Ameer Shahul shed light on the critical influence of pharmaceutical lobbies on public health policies. He argued that these powerful entities have often overshadowed the contributions of pioneering scientists and the vital role of the public sector in nurturing the country’s vaccine ecosystem.
Shahul traced the evolution of immunisation in India, emphasizing the remarkable achievements of scientists who dedicated their lives to vaccine development. He pointed out that many of these unsung heroes have been forgotten in the annals of history, overshadowed that frequently celebrate commercial success over scientific innovation. “We became hostages to pharmaceutical lobbies,” Shahul lamented, insisting that this has led to a distorted understanding of the vaccine landscape.
The public sector played an indispensable role in the early successes of immunisation in India. Shahul highlighted how government research institutions laid the groundwork for vaccine development, providing the necessary infrastructure, funding, and expertise that enabled scientists to innovate. However, with the increasing influence of the private sector in recent decades, he argued that the focus has shifted away from public benefit towards profit maximisation.
Shahul addressed the challenges faced initiatives, noting that the accessibility and affordability of vaccines are often dictated of pharmaceutical companies rather than the health needs of the population. With rising healthcare costs and the prioritisation of lucrative vaccine markets, he warned that vulnerable populations risk being left behind.
In this context, Shahul called for a renewed commitment to supporting public research initiatives and acknowledging the contributions of scientists who have fought for affordable, accessible healthcare solutions. He believes that fostering a collaborative environment between the public and private sectors could lead to a more equitable and robust immunisation framework in India.
As the conversation around vaccines becomes increasingly politicised, Shahul’s insights serve as a crucial reminder of the importance of balancing commercial interests with the fundamental right to health. Drawing attention to the forgotten pioneers of immunisation, he advocates for a broader recognition of their work, arguing that the future of public health in India depends on learning from the past and prioritising community well-being over corporate gain.
Related News
- Should I stay or should I go? Rural international students face housing, job crunch
- Sanjay Garg’s Raw Mango debuts at the London Fashion Week
- Inspiring Creativity with Morning Pages
- Kuwait oil refinery units on fire after drone attack: state media
- Pakistan's response to any attack would be 'swift, calibrated and decisive': Khawaja Asif on Rajnath Singh’s remarks
- Revisiting the timeless allure of classic cars at Udaipur’s Oberoi Concours d’Elegance 2026